Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes for hilar and extrahepatic cholangiocarcinoma with adjuvant, definitive, or liver transplant-based neoadjuvant chemoradiotherapy strategies: a single-center experience.
Laughlin BS, Petersen MM, Yu NY, Anderson JD, Rule WG, Borad MJ, Aqel BA, Sonbol MB, Mathur AK, Moss AA, Bekaii-Saab TS, Ahn DH, DeWees TA, Sio TT, Ashman JB. Laughlin BS, et al. J Gastrointest Oncol. 2022 Feb;13(1):288-297. doi: 10.21037/jgo-21-615. J Gastrointest Oncol. 2022. PMID: 35284111 Free PMC article.
Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery.
Thorpe CS, DeWees TA, Laughlin BS, Vallow LA, Seneviratne D, Pockaj BA, Cronin PA, Halyard MY, Vern-Gross TZ, McGee LA, McLaughlin SA, Voss MM, Golafshar MA, Bulman GF, Vargas CE. Thorpe CS, et al. Among authors: laughlin bs. Adv Radiat Oncol. 2022 Oct 21;8(1):101111. doi: 10.1016/j.adro.2022.101111. eCollection 2023 Jan-Feb. Adv Radiat Oncol. 2022. PMID: 36483068 Free PMC article.
Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy.
Laughlin BS, Voss MM, Toesca DAS, Daniels T, Golafshar MA, Keole SR, Wong WW, Rwigema JC, Davis B, Schild SE, Stish BJ, Choo R, Lester S, DeWees TA, Vargas CE. Laughlin BS, et al. Adv Radiat Oncol. 2022 Dec 10;8(2):101143. doi: 10.1016/j.adro.2022.101143. eCollection 2023 Mar-Apr. Adv Radiat Oncol. 2022. PMID: 36845611 Free PMC article.
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003.
Laughlin BS, Thorpe CS, DeWees TA, Voss MM, Chang JH, Hartsell WF, Sinesi CC, Rwigema JM, Keole SR, Gondi V, Vargas CE. Laughlin BS, et al. Adv Radiat Oncol. 2022 Dec 9;8(3):101142. doi: 10.1016/j.adro.2022.101142. eCollection 2023 May-Jun. Adv Radiat Oncol. 2022. PMID: 36896215 Free PMC article.
Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience.
Laughlin BS, Ebrahimi S, Voss MM, Patel SH, Foote RL, McGee LA, Garcia J, Ma DJ, Garces YI, Wittich MAN, Price KA, Schmitt A, Zhai Q, May BC, Nagel TH, Hinni ML, Chintakuntlawar AV, DeWees TA, Rwigema JM. Laughlin BS, et al. Adv Radiat Oncol. 2023 Mar 1;8(4):101204. doi: 10.1016/j.adro.2023.101204. eCollection 2023 Jul-Aug. Adv Radiat Oncol. 2023. PMID: 37152485 Free PMC article.
42 results